Clinical Trial Update: Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

View source ↗

Summary

This clinical trial update describes a study examining gene and protein expression patterns to predict cetuximab response in recurrent and/or metastatic head an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Head and Neck Cancer | Status: TERMINATED